(Q40537332)

English

Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response

scientific article published on July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response (English)

1 reference

Europe PubMed Central

21 September 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

0 references

author name string

Kenneth Flanagan

1

1 reference

Europe PubMed Central

21 September 2017

Robert T Glover

2

1 reference

Europe PubMed Central

21 September 2017

Heidi Hörig

3

1 reference

Europe PubMed Central

21 September 2017

Wancai Yang

4

1 reference

Europe PubMed Central

21 September 2017

Howard L Kaufman

5

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

22

1 reference

Europe PubMed Central

21 September 2017

21-22

1 reference

Europe PubMed Central

21 September 2017

2894-2903

1 reference

Europe PubMed Central

21 September 2017

Chemokines: agents for the immunotherapy of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Chemokines in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

The role of chemokine receptors in primary, effector, and memory immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Chemokines: signal lamps for trafficking of T and B cells for development and effector function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Chemokines and dendritic cell traffic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Chemokines and dendritic cells: a crucial alliance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Transfection of macrophage inflammatory protein 1 alpha into B16 F10 melanoma cells inhibits growth of pulmonary metastases but not subcutaneous tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Viral exploitation and subversion of the immune system through chemokine mimicry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

The role of CD8(+) T cells in immune responses to colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

An innate sense of danger

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.021

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.12.021

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40537332&oldid=2076965442"